BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News
Natco Pharma Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524816
ISIN Demat
INE987B01026
Book Value (Rs)
477.507017
NSE Symbol
NATCOPHARM
Divident Yield %
0.6
Market Cap
(Rs In Cr.)
14,796
P/E (TTM)
16.59
EPS (TTM)
49.8
Face Value
(Rs)
2
Date Heading
05-Sep-26 Natco Pharma to conduct board meeting
05-Sep-26 Natco Pharma to conduct AGM
25-Aug-26 Natco Pharma to further invest USD 14M in eGenesis Inc.
24-Aug-26 Stock Alert: Caplin Point Lab, Natco pharma, Federal Bank, B. R. Goyal
22-Aug-26 Natco Pharma announces conclusion of USFDA inspection of its Visakhapa
22-Aug-26 NATCO Pharma's Visakhapatnam unit gets Form 483 with 4 observations fr
14-Aug-26 Board of Natco Pharma recommends interim dividend
14-Aug-26 National Aluminium Company Ltd leads losers in 'A' group
07-Aug-26 Natco Pharma to convene board meeting
20-Jul-26 NATCO Pharma rallies after USFDA grants tentative approval for Olapari
14-Jul-26 Natco Pharma completes acquisition of additional 13.25% stake in Adcoc
03-Jun-26 NATCO Pharma, Lupin secure USFDA approval for Eribulin Mesylate inject
03-Jun-26 Lupin and alliance partner Natco receive USFDA approval for Eribulin M
30-May-26 Natco Pharma consolidated net profit declines 34.11% in the March 2026
29-May-26 Natco Pharma tanks after Q4 profit declines 34% YoY to Rs 268 cr
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)